Study ID: ABS-AS-201

Study Title

A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

Teva Identifier

ABS-AS-201

ClinicalTrials.gov Identifier

NCT01058863

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

02/01/2010 - 06/01/2010

Phase

Phase 2

Study Type

Interventional